// App-Quantinova.ai

949 : Assessment of Serum Bioactive Hepcidin-25, Soluble Transferrin Receptor and Their Ratio in Predialysis Patients: Correlation with the Response to Intravenous Ferric Carboxymaltose Administration

Researchers

Presenter

  • Athina Drakou

Principal Investigators

  • Christos Poziopoulos

  • Alexandra Margeli

  • Ioannis Papassotiriou

  • Demetrios Vlahakos

Medical Centers

  • Renal Unit, Attikon General University Hospital, University of Athens, School of Medicine, Athens, Greece

  • Department of Clinical Biochemistry, Aghia Sophia Childrens Hospital, Athens, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Polycystic kidney disease

  • Anemia

  • Chronic kidney disease

  • Diabetes

  • Renal disease

Biomarkers

  • Creatinine

  • Hepcidin antimicrobial peptide

  • High sensitivity C-reactive protein

  • Interleukin 6

  • TIMP Metallopeptidase Inhibitor 1

  • TNF Alpha Induced Protein 1

  • Transferrin

  • Body mass index

Drug/Treatment

  • Ferric carboxymaltose

  • Cyanocobalamin

  • FA-8

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved